Actavis acquires generics company Auden McKenzie
Executive Summary
Actavis PLC acquired private generics company Auden McKenzie Ltd. for $459.5mm (£306mm) in cash plus a two-year royalty on gross profit of a single Auden product. The deal excludes Auden's real estate portfolio.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash for Equity
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice